The Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
J Clin Endocrinol Metab. 2022 Feb 17;107(3):e924-e934. doi: 10.1210/clinem/dgab815.
The interrelationships among the gut microbiome, the Mediterranean diet (MedDiet), and a clinical endpoint of diabetes is unknown.
To identify gut microbial features of a MedDiet and examine whether the association between MedDiet and diabetes varies across individuals with different gut microbial profiles.
This study included 543 diabetic, 805 prediabetic, and 394 normoglycemic participants from a cohort study of USA Hispanic/Latino men and women. Fecal samples were profiled using 16S rRNA gene sequencing. Adherence to MedDiet was evaluated by an index based on 2 24-hour dietary recalls.
A greater MedDiet adherence was associated with higher abundances of major dietary fiber metabolizers (e.g., Faecalibacterium prausnitzii, false-discovery-rate-adjusted P [q] = 0.01), and lower abundances of biochemical specialists (e.g., Parabacteroides, q = 0.04). The gut microbiomes of participants with greater MedDiet adherence were enriched for functions involved in dietary fiber degradation but depleted for those related to sulfur reduction and lactose and galactose degradation. The associations between MedDiet adherence and diabetes prevalence were significantly stronger among participants with depleted abundance of Prevotella (pinteraction = 0.03 for diabetes, 0.02 for prediabetes/diabetes, and 0.02 for prediabetes). A 1-SD deviation increment in the MedDiet index was associated with 24% (odds ratio [OR] 0.76; 95% CI, 0.59-0.98) and 7% (OR 0.93; 95% CI, 0.72-1.20) lower odds of diabetes in Prevotella noncarriers and carriers, respectively.
Adherence to MedDiet is associated with diverse gut microorganisms and microbial functions. The inverse association between the MedDiet and diabetes prevalence varies significantly depending on gut microbial composition.
肠道微生物群、地中海饮食(MedDiet)和糖尿病临床终点之间的相互关系尚不清楚。
确定 MedDiet 的肠道微生物特征,并研究 MedDiet 与糖尿病之间的关联是否因个体肠道微生物特征不同而有所差异。
本研究纳入了来自美国西班牙裔/拉丁裔男性和女性队列研究的 543 名糖尿病患者、805 名糖尿病前期患者和 394 名血糖正常者。采用 16S rRNA 基因测序对粪便样本进行分析。采用基于 2 份 24 小时膳食回忆的指数评估 MedDiet 的依从性。
更高的 MedDiet 依从性与主要膳食纤维代谢物(如普氏粪杆菌,校正后的错误发现率[q] = 0.01)的丰度增加相关,而与生化专家(如拟杆菌属,q = 0.04)的丰度减少相关。与更高 MedDiet 依从性相关的肠道微生物组富含参与膳食纤维降解的功能,但缺乏与硫还原以及乳糖和半乳糖降解相关的功能。在 Prevotella 丰度减少的参与者中,MedDiet 依从性与糖尿病患病率之间的关联更为显著(交互作用 p 值分别为糖尿病:0.03,糖尿病前期/糖尿病:0.02,糖尿病前期:0.02)。MedDiet 指数的 1-SD 偏差增量与 Prevotella 非携带者和携带者糖尿病的发生几率分别降低 24%(比值比[OR]0.76;95%可信区间,0.59-0.98)和 7%(OR 0.93;95%可信区间,0.72-1.20)相关。
MedDiet 的依从性与肠道微生物群和微生物功能多样性有关。MedDiet 与糖尿病患病率之间的反比关系因肠道微生物组成的不同而有显著差异。